3-methyl-4-[(2S)-2-methyl-3-(trideuteriomethyl)-2H-imidazol-1-yl]-11H-indolo[1,2-a]benzimidazole
C20H20N4 — CID 159518197
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-methyl-4-[(2S)-2-methyl-3-(trideuteriomethyl)-2H-imidazol-1-yl]-11H-indolo[1,2-a]benzimidazole
3-methyl-4-[(2S)-2-methyl-3-(trideuteriomethyl)-2H-imidazol-1-yl]-11H-indolo[1,2-a]benzimidazole (PubChem CID 159518197) has the molecular formula C20H20N4 and a molecular weight of 319.43 g/mol. Its IUPAC name is 3-methyl-4-[(2S)-2-methyl-3-(trideuteriomethyl)-2H-imidazol-1-yl]-11H-indolo[1,2-a]benzimidazole.
Molecular Properties
| Compound Name | 3-methyl-4-[(2S)-2-methyl-3-(trideuteriomethyl)-2H-imidazol-1-yl]-11H-indolo[1,2-a]benzimidazole |
|---|---|
| PubChem CID | 159518197 |
| Molecular Formula | C20H20N4 |
| Molecular Weight | 319.43 g/mol |
| Exact Mass | 319.19 |
| IUPAC Name | 3-methyl-4-[(2S)-2-methyl-3-(trideuteriomethyl)-2H-imidazol-1-yl]-11H-indolo[1,2-a]benzimidazole |
| SMILES | [2H]C([2H])([2H])N1C=CN(c2c(C)ccc3c2-n2c(nc4ccccc42)C3)[C@H]1C |
| InChI | InChI=1S/C20H20N4/c1-13-8-9-15-12-18-21-16-6-4-5-7-17(16)24(18)20(15)19(13)23-11-10-22(3)14(23)2/h4-11,14H,12H2,1-3H3/t14-/m0/s1/i3D3 |
| InChIKey | GSSLLOQCKLPRPL-KKUKGAKGSA-N |
| XLogP | 3.81 |
| TPSA | 24.30 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 24 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 319.43 |
| LogP ≤ 5 | 3.81 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 159518197 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.